Latest & greatest articles for opioid

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on opioid or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on opioid and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for opioid

1. Injectable opioid treatment: commissioning and providing services

Injectable opioid treatment: commissioning and providing services Injectable opioid treatment: commissioning and providing services - GOV.UK Cookies on GOV.UK We use some essential cookies to make this website work. We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services. We also use cookies set by other sites to help us deliver content from their services. Accept additional cookies Reject additional cookies You can at any (...) time. Hide this message Show or hide search Search on GOV.UK Search Menu National lockdown: stay at home Check what you need to do Guidance Injectable opioid treatment: commissioning and providing services Guidance on commissioning and providing injectable opioid treatment for people with opioid dependence who have not responded to oral treatment. From: Published: 19 March 2021 Applies to: England Documents HTML HTML HTML HTML Details This guidance is for local authority commissioners and service

2021 Public Health England

2. Treating Opioid Use Disorder as a Chronic Condition: A Practice Manual for Family Physicians

deaths . 31 Buprenorphine As an opioid partial agonist, buprenorphine helps control cravings and prevents symptoms of opiate withdrawal while partially blocking the action of opiate agonists, such as heroin, prescription opiates, and synthetic opiates . High doses of buprenorphine do not cause higher levels of respiratory depression, making this medication significantly safer than full agonist opioids . Buprenorphine can also be used for treatment of pain in different formulations . 32 Buprenorphine (...) antagonist at the opioid receptor, blocking the effect of other opiates and reducing cravings . Abuse and diversion potential with naltrexone is limited, if any . If a patient has a return to use, naltrexone prevents all the effects of the illicit opioid . 37 Patients discontinuing the use of naltrexone experience a reduced tolerance to opioids . They may not be aware of their sensitivity to the same, or even lower doses of opioids they had previously taken . If patients return to use or relapse

2021 American Academy of Family Physicians

3. Opioid-Associated Out-of-Hospital Cardiac Arrest: Distinctive Clinical Features and Implications for Health Care and Public Responses: A Scientific Statement From the American Heart Association Full Text available with Trip Pro

Opioid-Associated Out-of-Hospital Cardiac Arrest: Distinctive Clinical Features and Implications for Health Care and Public Responses: A Scientific Statement From the American Heart Association Opioid-Associated Out-of-Hospital Cardiac Arrest: Distinctive Clinical Features and Implications for Health Care and Public Responses: A Scientific Statement From the American Heart Association | Circulation Search Search Hello Guest! Login to your account Email Password Keep me logged in Search Search (...) March 2021 February 2021 January 2021 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access Review Article Share on Jump to Free Access Review Article Opioid-Associated Out-of-Hospital Cardiac Arrest: Distinctive Clinical Features and Implications for Health Care and Public Responses: A Scientific Statement From the American Heart Association , MD, Vice Chair , MD, MSc, MPH , MD, Chair , MD, MS , MD, SM , MD , MD , MD, PhD , MD, MSCE , MD , MD

2021 American Heart Association

4. The use of oral opioids to control children’s pain in the post-codeine era

in place of codeine, but data are limited regarding their efficacy and safety in children. While the same pathways metabolize oral oxycodone as codeine, oxycodone’s pharmacokinetics vary widely. There are also limited data on the safety and efficacy of oral hydromorphone and tramadol use for children. Oral morphine is the opiate alternative to codeine for which there is the most evidence of safety and efficacy in children. Research is needed to investigate both other opioids and non-opioid (...) The use of oral opioids to control children’s pain in the post-codeine era Pain is a common problem for children, and pain management comprises both pharmacologic and nonpharmacologic measures. For moderate to severe pain, oral opioids have been a popular choice for the last few decades. Codeine has historically been the best-known oral opioid for use in children. However, availability and use of codeine have sharply declined due to safety concerns. A variety of other opioids have been used

2021 Canadian Paediatric Society

5. Surgery and Opioids: Best Practice Guidelines 2021

Surgery and Opioids: Best Practice Guidelines 2021 March 2021 Surgery and Opioids: Best Practice Guidelines 2021Contents Introduction 3 Membership of the Working Party 4 Executive Summary 5 Preoperative Recommendations 5 Intraoperative Recommendations 5 Postoperative Recommendations 6 Post Discharge Management 7 Detailed Recommendations 7 Preoperative Recommendations (Detailed) 7 Intraoperative Recommendations (Detailed) 8 Post Operative Recommendations (Detailed) 9 Recommendations for Post (...) Anaesthesia Care Unit (PACU) 9 Recommendations for the Ward 10 Discharge Planning 11 Additional recommendations for opioid tolerant patients 11 Post Discharge Management (Detailed) 12 Appendix A 13 Approximate equi-analgesic potencies of opioids for oral administration 13 Transdermal Opioids 14 References 15 Surgery and Opiods Best Practice Guidelines 2021 2 © Faculty of Pain Medicine 2021Introduction There is a duty on all practitioners and professional bodies to be responsive to public and governmental

2021 Faculty of Pain Medicine

6. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, OPRM1, and COMT genotype and select opioid therapy

Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, OPRM1, and COMT genotype and select opioid therapy This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/CPT.2149 This article is protected by copyright. All rights reserved DR MENG (...) -YU WU (Orcid ID : 0000-0002-8773-1847) Article type : CPIC Update Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, OPRM1, and COMT genotype and select opioid therapy Kristine R. Crews 1 , Andrew A. Monte 2 , Rachel Huddart 3 , Kelly E. Caudle 1 , Evan D. Kharasch 4 , Andrea Gaedigk 5,6 , Henry M. Dunnenberger 7 , J. Steven Leeder 5,6 , John T. Callaghan 8 , Caroline Flora Samer 9 , Teri E. Klein 3 , Cyrine E. Haidar 1 , Sara L. Van Driest 10 , Gualberto Ruano 11

2021 Clinical Pharmacogenetics Implementation Consortium

7. Guidelines for Opioid Prescribing in Children and Adolescents After Surgery: An Expert Panel Opinion

Guidelines for Opioid Prescribing in Children and Adolescents After Surgery: An Expert Panel Opinion Guidelines for Opioid Prescribing in Children and Adolescents After Surgery: An Expert Panel Opinion - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. National Institutes of Health (...) software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation JAMA Surg Actions . 2021 Jan 1;156(1):76-90. doi: 10.1001/jamasurg.2020.5045. Guidelines for Opioid Prescribing in Children and Adolescents After Surgery: An Expert Panel Opinion , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Division of Pediatric Surgery, Children's

2021 EvidenceUpdates

8. Comparison of Monotherapy Versus Combination of Intravenous Ibuprofen and Propacetamol (Acetaminophen) for Reduction of Postoperative Opioid Administration in Children Undergoing Laparoscopic Hernia Repair: A Double-Blind Randomized Controlled Trial

Comparison of Monotherapy Versus Combination of Intravenous Ibuprofen and Propacetamol (Acetaminophen) for Reduction of Postoperative Opioid Administration in Children Undergoing Laparoscopic Hernia Repair: A Double-Blind Randomized Controlled Trial Comparison of Monotherapy Versus Combination of Intravenous Ibuprofen and Propacetamol (Acetaminophen) for Reduction of Postoperative Opioid Administration in Children Undergoing Laparoscopic Hernia Repair: A Double-Blind Randomized Controlled Trial (...) Anesth Analg Actions . 2020 Nov 10. doi: 10.1213/ANE.0000000000005284. Online ahead of print. Comparison of Monotherapy Versus Combination of Intravenous Ibuprofen and Propacetamol (Acetaminophen) for Reduction of Postoperative Opioid Administration in Children Undergoing Laparoscopic Hernia Repair: A Double-Blind Randomized Controlled Trial , , , , Affiliations Expand Affiliations 1 From the Department of Anesthesiology and Pain Medicine. 2 Anesthesia and Pain Research Institute, Yonsei University

2021 EvidenceUpdates

9. Buprenorphine/naloxone (Suboxone) - opioid drug dependence

Buprenorphine/naloxone (Suboxone) - opioid drug dependence Published 08 February 2021 1 Product update SMC2316 buprenorphine/naloxone 2mg/0.5mg and 8mg/2mg sublingual film (Suboxone®) Indivior UK Limited 15 January 2021 The Scottish Medicines Consortium has completed its assessment of the above product and, following review by the SMC executive, advises NHS Boards and Area Drug and Therapeutics Committees (ADTCs) on its use in NHSScotland. The advice is summarised as follows: ADVICE: following (...) an abbreviated submission buprenorphine/naloxone sublingual film (Suboxone®) is accepted for restricted use within NHSScotland. Indication under review: substitution treatment for opioid drug dependence, within a framework of medical, social and psychological treatment. The intention of the naloxone component is to deter intravenous misuse. Buprenorphine/naloxone is indicated in adults and adolescents over 15 years of age who have agreed to be treated for addiction. SMC restriction: to those patients in whom

2021 Scottish Medicines Consortium

10. Transmuscular quadratus lumborum block reduces opioid consumption and prolongs time to first opioid demand after laparoscopic nephrectomy

Transmuscular quadratus lumborum block reduces opioid consumption and prolongs time to first opioid demand after laparoscopic nephrectomy Transmuscular quadratus lumborum block reduces opioid consumption and prolongs time to first opioid demand after laparoscopic nephrectomy - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 (...) : 10.1136/rapm-2020-101745. Epub 2020 Oct 26. Transmuscular quadratus lumborum block reduces opioid consumption and prolongs time to first opioid demand after laparoscopic nephrectomy , , , , , , , , Affiliations Expand Affiliations 1 Department of Anaesthesiology, Zealand University Hospital, Roskilde, Denmark. 2 Department of Urology, Zealand University Hospital, Roskilde, Denmark. 3 Nørresundby, Denmark. 4 Anaesthesiology, Norfolk and Norwich University Hospital NHS Trust, Norwich, Norfolk, UK. 5

2021 EvidenceUpdates

11. Digital Health Technologies as an Adjunct to Medication Assisted Therapy for Opioid Use Disorder: Final Policy Recommendations

Digital Health Technologies as an Adjunct to Medication Assisted Therapy for Opioid Use Disorder: Final Policy Recommendations ©Institute for Clinical and Economic Review, 2020 Page 1 Digital Health Technologies as an Adjunct to Medication Assisted Therapy for Opioid Use Disorder: Final Policy Recommendations December 11, 2020 ©Institute for Clinical and Economic Review, 2020 Page 2 Policy Recommendations Introduction The following policy recommendations reflect main themes in the report (...) and those discussed during the Policy Roundtable discussion at the November 18, 2020 Midwest CEPAC public meeting on the use of digital health technologies (DHTs) as an adjunct to medication assisted treatment for opioid use disorder. At the meeting, ICER presented the findings of its revised report on these treatments and the Midwest CEPAC voting council deliberated on key questions related to their comparative clinical effectiveness, potential other benefits and contextual considerations, and long

2020 California Technology Assessment Forum

12. Benefits and Harms of Long-term Opioid Dose Reduction or Discontinuation in Patients with Chronic Pain: a Rapid Review

Benefits and Harms of Long-term Opioid Dose Reduction or Discontinuation in Patients with Chronic Pain: a Rapid Review Benefits and Harms of Long-term Opioid Dose Reduction or Discontinuation in Patients with Chronic Pain: a Rapid Review - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving (...) . Benefits and Harms of Long-term Opioid Dose Reduction or Discontinuation in Patients with Chronic Pain: a Rapid Review , , , , Affiliations Expand Affiliations 1 Evidence Synthesis Program (ESP) Coordinating Center, VA Portland Health Care System, R&D 71 3710 SW U.S. Veterans Hospital Road, Portland, OR, USA. katherine.mackey@va.gov. 2 Evidence Synthesis Program (ESP) Coordinating Center, VA Portland Health Care System, R&D 71 3710 SW U.S. Veterans Hospital Road, Portland, OR, USA. PMID: 33145689 DOI

2020 EvidenceUpdates

13. Managing Acute Pain in Patients Taking Medication for Opioid Use Disorder: a Rapid Review

Managing Acute Pain in Patients Taking Medication for Opioid Use Disorder: a Rapid Review Managing Acute Pain in Patients Taking Medication for Opioid Use Disorder: a Rapid Review - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public health information from CDC (...) Medication for Opioid Use Disorder: a Rapid Review , , , Affiliations Expand Affiliations 1 Evidence Synthesis Program (ESP) Coordinating Center, VA Portland Health Care System, Portland, OR, USA. stephanie.veazie@va.gov. 2 Evidence Synthesis Program (ESP) Coordinating Center, VA Portland Health Care System, Portland, OR, USA. PMID: 33145688 DOI: Item in Clipboard Review Managing Acute Pain in Patients Taking Medication for Opioid Use Disorder: a Rapid Review Stephanie Veazie et al. J Gen Intern Med

2020 EvidenceUpdates

14. Comparison of Pupillometry With Surgical Pleth Index Monitoring on Perioperative Opioid Consumption and Nociception During Propofol-Remifentanil Anesthesia: A Prospective Randomized Controlled Trial

Comparison of Pupillometry With Surgical Pleth Index Monitoring on Perioperative Opioid Consumption and Nociception During Propofol-Remifentanil Anesthesia: A Prospective Randomized Controlled Trial Comparison of Pupillometry With Surgical Pleth Index Monitoring on Perioperative Opioid Consumption and Nociception During Propofol-Remifentanil Anesthesia: A Prospective Randomized Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage (...) Display options Format Share Permalink Copy Page navigation Randomized Controlled Trial Anesth Analg Actions . 2020 Nov;131(5):1589-1598. doi: 10.1213/ANE.0000000000004958. Comparison of Pupillometry With Surgical Pleth Index Monitoring on Perioperative Opioid Consumption and Nociception During Propofol-Remifentanil Anesthesia: A Prospective Randomized Controlled Trial , , , , , Affiliations Expand Affiliations 1 From the Department of Anesthesiology and Pain Medicine, Daegu Catholic University

2020 EvidenceUpdates

15. Naldemedine (opioid-induced constipation) - Benefit assessment according to §35a Social Code Book V

Naldemedine (opioid-induced constipation) - Benefit assessment according to §35a Social Code Book V 1 Translation of Sections 2.1 to 2.5 of the dossier assessment Naldemin (opioidinduzierte Obstipation) – Nutzenbewertung gemäß § 35a SGB V (Version 1.0; Status: 13 August 2020). Please note: This document was translated by an external translator and is provided as a service by IQWiG to English-language readers. However, solely the German original text is absolutely authoritative and legally (...) binding. Extract IQWiG Reports – Commission No. A20-45 Naldemedine (opioid-induced constipation) – Benefit assessment according to §35a Social Code Book V 1 Extract of dossier assessment A20-45 Version 1.0 Naldemedine (opioid-induced constipation) 13 August 2020 Institute for Quality and Efficiency in Health Care (IQWiG) - i - Publishing details Publisher Institute for Quality and Efficiency in Health Care Topic Naldemedine (opioid-induced constipation) – Benefit assessment according to §35a Social

2020 Institute for Quality and Efficiency in Healthcare (IQWiG)

16. The Association Between Prescribed Opioid Receipt and Community-Acquired Pneumonia in Adults: a Systematic Review and Meta-analysis

The Association Between Prescribed Opioid Receipt and Community-Acquired Pneumonia in Adults: a Systematic Review and Meta-analysis The Association Between Prescribed Opioid Receipt and Community-Acquired Pneumonia in Adults: a Systematic Review and Meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 (...) : 10.1007/s11606-020-06155-9. Epub 2020 Sep 3. The Association Between Prescribed Opioid Receipt and Community-Acquired Pneumonia in Adults: a Systematic Review and Meta-analysis , , , , , Affiliations Expand Affiliations 1 Pain Research, Informatics, Multi-morbidities, and Education (PRIME) Center, VA Connecticut Healthcare System West Haven, West Haven Campus, Research Office/151, 950 Campbell Avenue, West Haven, CT, 06516-2770, USA. 2 Yale School of Medicine, New Haven, CT, USA. 3 Pain Research

2020 EvidenceUpdates

17. A randomized controlled noninferiority trial of reduced vs routine opioid prescription after prolapse repair

A randomized controlled noninferiority trial of reduced vs routine opioid prescription after prolapse repair A randomized controlled noninferiority trial of reduced vs routine opioid prescription after prolapse repair - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest (...) . A randomized controlled noninferiority trial of reduced vs routine opioid prescription after prolapse repair , , , , , , Affiliations Expand Affiliations 1 Center for Urogynecology & Pelvic Reconstructive Surgery, Obstetrics, Gynecology & Women's Health Institute, Cleveland Clinic, Cleveland, OH. Electronic address: edavidson@mcw.edu. 2 Center for Urogynecology & Pelvic Reconstructive Surgery, Obstetrics, Gynecology & Women's Health Institute, Cleveland Clinic, Cleveland, OH. 3 Quantitative Health Sciences

2020 EvidenceUpdates

18. Does Intravenous Acetaminophen Reduce Opioid Requirement in Pediatric Emergency Department Patients With Acute Sickle Cell Crises?

Does Intravenous Acetaminophen Reduce Opioid Requirement in Pediatric Emergency Department Patients With Acute Sickle Cell Crises? Does Intravenous Acetaminophen Reduce Opioid Requirement in Pediatric Emergency Department Patients With Acute Sickle Cell Crises? - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging (...) . Does Intravenous Acetaminophen Reduce Opioid Requirement in Pediatric Emergency Department Patients With Acute Sickle Cell Crises? , , Affiliations Expand Affiliation 1 From the, Pediatric Emergency Department, Children's Hospital of New Jersey at Newark Beth Israel Medical Center, Newark, NJ, USA. PMID: 33025690 DOI: Item in Clipboard Does Intravenous Acetaminophen Reduce Opioid Requirement in Pediatric Emergency Department Patients With Acute Sickle Cell Crises? Tina Dhebaria et al. Acad Emerg

2020 EvidenceUpdates

19. Prevention, Diagnosis, and Management of Opioids, Opioid Misuse, and Opioid Use Disorder in Older Adults

Prevention, Diagnosis, and Management of Opioids, Opioid Misuse, and Opioid Use Disorder in Older Adults Prevention, Diagnosis, and Management of Opioids, Opioid Misuse, and Opioid Use Disorder in Older Adults Technical Brief Number 37 RTechnical Brief Number 37 Prevention, Diagnosis, and Management of Opioids, Opioid Misuse, and Opioid Use Disorder in Older Adults Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville (...) acknowledgment and citation of its work. Suggested language for acknowledgment: This work was based on an evidence report, Prevention, Diagnosis, and Management of Opioids, Opioid Misuse, and Opioid Use Disorder in Older Adults, by the Evidence-based Practice Center Program at the Agency for Healthcare Research and Quality (AHRQ). Suggested citation: Zullo AR, Danko KJ, Moyo P, Adam GP, Riester M, Kimmel HJ, Panagiotou OA, Beaudoin FL, Carr D, Balk EM. Prevention, Diagnosis, and Management of Opioids, Opioid

2020 Effective Health Care Program (AHRQ)

20. Opioids: risk of dependence and addiction

Opioids: risk of dependence and addiction Opioids: risk of dependence and addiction - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Show or hide search Search on GOV.UK Search National restrictions in England from 5 November Take action now for new rules in 2021 Opioids: risk of dependence (...) and addiction New recommendations following a review of the risks of dependence and addiction associated with prolonged use of opioid medicines (opioids) for non-cancer pain. Before prescribing opioids, discuss with the patient the risks and features of tolerance, dependence, and addiction, and agree together a treatment strategy and plan for end of treatment. Published 23 September 2020 From: Therapeutic area: Contents Advice for healthcare professionals: opioid medicines (opioids) provide relief from

2020 MHRA Drug Safety Update